Igentify
Igentify is an Israeli private VC-backed digital genomics platform company streamlining genetic testing workflows for patients, labs, and providers with dual-use military biodefense and personnel genetic screening applications.
Visit WebsiteCompany Overview
Igentify develops a digital platform that securely streamlines the entire genomic workflow, helping patients, laboratories, and healthcare providers access, interpret, and guide the use of genetic information more effectively. The platform integrates genetic counseling, test ordering, result delivery, and patient education into a unified digital experience.
The company serves healthcare systems, genetic testing laboratories, and clinical genetics practices, reducing the bottleneck of limited genetic counselors through AI-assisted digital genetic counseling and automated patient education.
Dual-use relevance is meaningful: the same digital genomics platform that streamlines civilian genetic testing can be adapted for military biodefense applications including rapid personnel genetic screening for susceptibility to biological agents, pharmacogenomics for optimizing military medical treatments, and population-scale genetic surveillance for bioterrorism early warning systems.
Dual-Use Assessment
Digital genomics workflow platforms have dual-use applications in civilian genetic testing and military biodefense screening, pharmacogenomics, and biosurveillance.
Key Technologies
- AI-assisted digital genetic counseling
- Automated genomic workflow management
- Patient genetic education and consent platform
- Secure genetic data handling and compliance
- Laboratory result integration and interpretation
Use Cases & Applications
- Clinical genetic testing workflow automation
- Patient genetic counseling and education
- Military personnel genetic screening for agent susceptibility
- Pharmacogenomics for optimized military medical treatment
- Biodefense population genetic surveillance
Strategic Value to U.S.-Israel Alliance
Enables allied military biodefense programs with scalable digital genomics platform for personnel screening and biological threat assessment.
Interested in this startup?
Learn more about our investment approach or get in touch to discuss opportunities in dual-use technology.